What Targeted Oncology does

Targeted Oncology is a privately held digital media and publishing company serving oncology healthcare professionals. The company operates targetedonc.com as its primary platform, distributing specialized editorial content covering immunotherapy, biomarkers, cancer pathways, FDA briefs, clinical trial information, and conference coverage to a persona-segmented audience of medical oncologists, cancer specialists, and oncology care providers.

The company's core offering is a portfolio of publications and multimedia properties. This includes three core clinical publications — Evolving Paradigms in Oncology, Peers & Perspectives in Oncology, and Targeted Therapies in Oncology — supported by video series (Case-Based Peer Perspectives, Expert Perspective Virtual Tumor Board, Pivotal Practice Views), podcasts (Data Dialogue with the Oncology Brothers), webinars, and a news platform (The Targeted Pulse). Educational programming extends through CME/CE-accredited content, case-based roundtable series, and the Precision Medicine Perspectives resource series, while the Oncology Icons program provides physician recognition. The platform aggregates FDA briefs, clinical trial listings, treatment resources, and conference coverage into a unified professional oncology information hub.

The business model is that of a niche B2B medical publisher monetizing through a digital-first, multi-channel distribution approach. Revenue mechanics are not publicly disclosed, but the presence of Sponsored Content and Press Releases resources, advertising-supported channels, and CME/CE programming indicate a mix of pharmaceutical/medical-device sponsorship, sponsored editorial, advertising, and continuing-education fees. The company is headquartered in Plainsboro, United States, with a reported headcount of 1-10 employees, and is privately held with no disclosed parent company, institutional investors, or funding rounds.

Name

Targeted Oncology

Legal name

Targeted Oncology

Website

http://www.targetedonc.com/

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Targeted Oncology is a privately held digital media and publishing company that delivers oncology-focused clinical news, peer-reviewed publications, video, podcasts, webinars, and CME/CE programming to medical oncologists, cancer specialists, and oncology healthcare professionals.

Ownership category

akta.pro rank

Product category

Oncology Medical Publishing

NAICS

Software Publishers (513210)

SIC

Services-Health Services (8000)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

Keywords

• Oncology medical publishing
• Cancer clinical education
• Continuing medical education
• Oncology news media
• Precision oncology content

Headquarters

HQ city

Plainsboro

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Distribution channels1 record

Marketing channels5 records

Core offering

Targeted Oncology is a multi-platform oncology content and publishing company that produces peer-reviewed clinical publications, news coverage, FDA briefs, conference reporting, and CME/CE-accredited educational programming for oncology healthcare professionals. Its core deliverable is specialized medical journalism and clinician education focused on immunotherapy, biomarkers, targeted therapies, and precision medicine in oncology, delivered through a website, video series, podcasts, webinars, and clinical trial resources.

Product overview

Targeted Oncology is a multi-platform content and publication company serving the oncology professional community. The core offering consists of a portfolio of peer-reviewed and clinical publications including Evolving Paradigms in Oncology, Peers & Perspectives in Oncology, and Targeted Therapies in Oncology. These publications are complemented by multimedia content platforms such as video series (Case-Based Peer Perspectives, Expert Perspective Virtual Tumor Board), podcasts (Data Dialogue with the Oncology Brothers), and webinars. The company also operates educational programs including the Case-Based Roundtable Series, CME/CE activities, and the Oncology Icons recognition program. The platform integrates conference coverage, FDA briefs, clinical trial information, and treatment resources into a unified professional oncology information hub.

Differentiator

Problem solved

Functional benefit

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• OncLive: OncLive is the closest direct competitor: an HCP-focused oncology media platform offering peer perspectives, video, podcasts, conference coverage, and CME/CE for practicing oncologists, with overlapping products across the same channels Targeted Oncology operates.
• Clinical Care Options Oncology: Clinical Care Options Oncology provides oncology-focused CME/CE, expert commentary, and conference coverage to practicing oncologists, making it a close functional peer for sponsored medical education.
• Cancer Network / MJH Life Sciences: Cancer Network (part of MJH Life Sciences) provides oncology news, peer-reviewed content, and conference coverage to oncologists, with overlapping sub-brands including OncLive and Medical World News referenced from Targeted Oncology's own navigation.
• OncLive Nursing / Oncology Nursing News: Oncology Nursing News covers oncology and supportive care from the nursing and advanced-practice perspective, serving an adjacent but overlapping segment of the oncology care team with similar conference and CME programming.
• American Society of Clinical Oncology (ASCO): ASCO's publishing arm (ASCO Post, JCO) and educational channels deliver oncology clinical news, expert commentary, and CME to the same practicing oncologist audience, competing head-on for attention and CME credit.
• PracticeUpdate Oncology: PracticeUpdate Oncology is a clinician-facing oncology news and conference coverage platform serving practicing oncologists with curated trial and treatment updates, competing for the same professional audience.
• Healio Oncology: Healio Oncology is a specialty-division of a physician media company providing oncology news, conference coverage, and CME/CE for the same HCP segment Targeted Oncology addresses.

Emerging players

• Doximity Oncology / Pulmonology channels: Doximity's physician-only network surfaces oncology-relevant news, podcasts, and CME-eligible content to oncologists, providing a digitally native, broader-scope channel that competes for HCP attention and CME credit.

Broad incumbents

• European Society for Medical Oncology (ESMO): ESMO is the European counterpart to ASCO and publishes oncology news, journals, and educational content for oncologists globally, serving many of the same educational and CME/CE needs that Targeted Oncology addresses.
• Medscape Oncology: Medscape Oncology is the oncology vertical of a broad, established physician media platform with news, conference coverage, and CME/CE; it overlaps with Targeted Oncology's audience but is part of a much larger multi-specialty portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/targetedonc
• Facebookfacebook.com/TargetedOnc
• LinkedInlinkedin.com/company/greg-kennelty-a27aa6103

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Targeted Oncology